Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
B-Cell Lymphoma
Research reports from La Sapienza University provide new insights into B-cell lymphoma
December 23rd, 2008
In this recent study, researchers in Rome, Italy conducted a study "To report the clinical findings and long-term results of front-line, third-generation MACOP-B (methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin) chemotherapy and mediastinal involved-field radiotherapy (IFRT) in 85 consecutive, previously untreated patients with primary mediastinal large B cell lymphoma (PMLBCL) diagnosed and managed at a single institution. Between 1991 and April 2004, 92 consecutive, untreated patients with PMLBCL were treated at our institution." "The median age was 33 years (range, 15-61 years), 46 patients (50%) showed a mediastinal syndrome at...
Source: Cancer Weekly (2008-12-23)
|
